Chr. Hansen Buys Biotech Firm

Chr. Hansen has acquired privately owned biotech firm Urex Biotech (Toronto), which focuses on human health and nutrition concerns. Terms were not disclosed. The deal expands Chr. Hansen’s portfolio of probiotics for dietary supplements, Chr. Hansen says. The companies partnered in 2004 to develop therapeutic products based on probiotic strains, targeting women’s health...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers